A
6.00
0.18 (3.09%)
| Previous Close | 5.82 |
| Open | 5.99 |
| Volume | 258,820 |
| Avg. Volume (3M) | 252,064 |
| Market Cap | 82,783,200 |
| Price / Book | 9.20 |
| 52 Weeks Range | |
| Earnings Date | 8 Nov 2024 |
| Diluted EPS (TTM) | -4.22 |
| Current Ratio (MRQ) | 2.66 |
| Operating Cash Flow (TTM) | -22.97 M |
| Levered Free Cash Flow (TTM) | -11.57 M |
| Return on Assets (TTM) | -154.58% |
| Return on Equity (TTM) | -596.70% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Mixed |
| Biotechnology (Global) | Mixed | Mixed | |
| Stock | Annovis Bio, Inc. | Bearish | Bearish |
AIStockmoo Score
0.0
| Analyst Consensus | 3.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | -1.0 |
| Technical Oscillators | -2.5 |
| Average | 0.00 |
|
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 20.40% |
| % Held by Institutions | 8.83% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Quest Partners Llc | 30 Sep 2024 | 46,002 |
| Wescott Financial Advisory Group, Llc | 30 Sep 2024 | 41,607 |
| Sterling Investment Advisors, Ltd. | 30 Sep 2024 | 34,474 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 30.00 (HC Wainwright & Co., 400.00%) | Buy |
| Median | 23.00 (283.33%) | |
| Low | 21.00 (D. Boral Capital, 250.00%) | Buy |
| 21.00 (EF Hutton, 250.00%) | Buy | |
| Average | 24.25 (304.17%) | |
| Total | 4 Buy | |
| Avg. Price @ Call | 8.29 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| D. Boral Capital | 11 Nov 2024 | 21.00 (250.00%) | Buy | 7.65 |
| HC Wainwright & Co. | 11 Nov 2024 | 30.00 (400.00%) | Buy | 7.65 |
| 16 Oct 2024 | 30.00 (400.00%) | Buy | 9.14 | |
| Maxim Group | 25 Oct 2024 | 25.00 (316.67%) | Buy | 9.87 |
| EF Hutton | 15 Oct 2024 | 21.00 (250.00%) | Buy | 7.98 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |